Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-08-004895
Filing Date
2008-03-17
Accepted
2008-03-17 15:26:44
Documents
7
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d54872e10vk.htm 10-K 927651
2 EMPLOYMENT AGREEMENT d54872exv10w18xdy.htm EX-10.18(D) 22770
3 LIST OF SUBSIDIARIES d54872exv21w1.htm EX-21.1 2683
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d54872exv23w1.htm EX-23.1 1606
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO d54872exv31w1.htm EX-31.1 14132
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO d54872exv32w1.htm EX-32.1 5240
7 GRAPHIC d54872d5487201.gif GRAPHIC 6871
  Complete submission text file 0000950134-08-004895.txt   985092
Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Filer) CIK: 0001018710 (see all company filings)

EIN.: 742704230 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21291 | Film No.: 08692684
SIC: 2834 Pharmaceutical Preparations